Your browser is no longer supported. Please, upgrade your browser.
Settings
QTRX Quanterix Corporation daily Stock Chart
QTRX [NASD]
Quanterix Corporation
Index- P/E- EPS (ttm)-1.67 Insider Own9.10% Shs Outstand26.63M Perf Week18.94%
Market Cap685.67M Forward P/E- EPS next Y-1.65 Insider Trans-3.03% Shs Float25.41M Perf Month9.81%
Income-39.20M PEG- EPS next Q-0.43 Inst Own83.50% Short Float4.78% Perf Quarter27.92%
Sales51.70M P/S13.26 EPS this Y82.70% Inst Trans0.12% Short Ratio8.91 Perf Half Y-21.54%
Book/sh5.12 P/B5.03 EPS next Y5.20% ROA-37.50% Target Price33.75 Perf Year28.75%
Cash/sh- P/C- EPS next 5Y- ROE-54.70% 52W Range19.08 - 36.15 Perf YTD8.97%
Dividend- P/FCF- EPS past 5Y- ROI-64.80% 52W High-28.77% Beta-
Dividend %- Quick Ratio7.00 Sales past 5Y- Gross Margin48.70% 52W Low34.96% ATR1.16
Employees177 Current Ratio7.60 Sales Q/Q40.60% Oper. Margin-76.60% RSI (14)62.72 Volatility6.75% 4.75%
OptionableNo Debt/Eq0.06 EPS Q/Q-6.80% Profit Margin-75.80% Rel Volume1.11 Prev Close25.33
ShortableYes LT Debt/Eq0.06 EarningsFeb 07 AMC Payout- Avg Volume136.41K Price25.75
Recom- SMA2010.25% SMA508.19% SMA2001.47% Volume151,981 Change1.66%
Jan-10-20 02:03PM  Quanterix Corporation to Present at 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-19-19 04:23PM  Hedge Funds Have Never Been This Bullish On Quanterix Corporation (QTRX) Insider Monkey
Dec-11-19 10:27AM  Does The Quanterix Corporation (NASDAQ:QTRX) Share Price Fall With The Market? Simply Wall St.
Nov-06-19 04:01PM  Quanterix Corporation Releases Operating Results for Third Quarter 2019 Business Wire -5.07%
Nov-04-19 04:00PM  Siemens Healthineers Enters into License and Supply Arrangement with Quanterix for Access to Neurofilament Light (Nf-L) Antibodies to Develop Nf-L Assays Business Wire
Nov-01-19 09:41AM  Hedge Funds Have Never Been More Bullish On Quanterix Corporation (QTRX) Insider Monkey
Oct-25-19 09:13AM  Quanterix Simoa Technology Unlocks Low-Level Markers Critical to Rapid Triage Test in Study for Active Pulmonary Tuberculosis Business Wire
Oct-22-19 04:30PM  Quanterix to Release Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019 Business Wire
Oct-18-19 11:13AM  3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
Oct-03-19 09:00AM  Quanterix Announces Recipients of Annual Accelerator Grant Program Business Wire +11.06%
Oct-01-19 09:46AM  Need To Know: Quanterix Corporation (NASDAQ:QTRX) Insiders Have Been Selling Shares Simply Wall St.
Sep-26-19 07:00AM  Sherlock Bio gets DoD grant to bring CRISPR to the battlefield American City Business Journals
Sep-24-19 01:14PM  Powering Precision Health Announces 2019 Summit Business Wire -5.86%
Sep-16-19 06:21PM  Quanterix Serum Nf-L Assay Powers Key Trial and Study Results Presented at ECTRIMS 2019 Business Wire
Sep-11-19 08:00AM  Quanterix Simoa Technology Powers Multiple Sclerosis Research with More Than 50 Presentations at ECTRIMS 2019 Business Wire +7.48%
Aug-13-19 04:21PM  Quanterix Announces Closing of Public Offering Including Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Aug-09-19 07:45AM  Quanterix Prices Public Offering of Common Stock Business Wire
Aug-07-19 04:23PM  Quanterix Announces Proposed Public Offering of Common Stock Business Wire
08:25AM  Quanterix Corporation (QTRX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 08:30AM  Quanterix Corporation Releases Operating Results for Second Quarter 2019 Business Wire
Jul-31-19 09:00AM  Quanterix to Present at the Canaccord Genuity 39th Annual Growth Conference Business Wire
Jul-30-19 10:30AM  Quanterix to Release Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6, 2019 Business Wire
Jul-26-19 11:16AM  Sarah Hlavinka Elected to Quanterix Board of Directors Business Wire
Jul-11-19 01:30PM  Quanterix to Convene Leading Industry Researchers at Alzheimers Association International Conference 2019 Following Closing of UmanDiagnostics Acquisition Business Wire
Jun-28-19 12:15PM  Quanterix Announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year® 2019 Award Winner in New England Business Wire
Jun-27-19 10:43AM  Mass. diagnostics firms sign M&A deals worth $500M American City Business Journals +8.95%
Jun-26-19 04:00PM  Quanterix Announces Agreement to Acquire UmanDiagnostics, Worlds Leading Neurofilament Light (Nf-L) Antibody Supplier Business Wire
Jun-06-19 07:03AM  Did Quanterix's (NASDAQ:QTRX) Share Price Deserve to Gain 66%? Simply Wall St.
Jun-04-19 04:00PM  Quanterix Raises $49.7 Million and Announces Introduction of Latest Model Simoa HD-X Analyzer at BIO 2019 International Convention Business Wire
May-29-19 04:00PM  Quanterix Expands Headquarters to New, State-of-the-Art Facility in Billerica, Mass. as Demand Continues to Grow for its Disruptive Simoa Platforms Business Wire
May-16-19 10:30AM  Quanterix Announces $50,000 in Grants to Support Promising Oncology Research Business Wire
May-11-19 01:27PM  Heres What Hedge Funds Think About Quanterix Corporation (QTRX) Insider Monkey
May-10-19 11:23AM  Quanterix Corporation (QTRX) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 04:00PM  Quanterix Corporation Releases Operating Results for First Quarter 2019 Business Wire
May-06-19 11:30AM  Quanterix Simoa Technology Powers More Than 85 Percent of Neurofilament Light Biomarker Research to be Unveiled at American Academy of Neurology Annual Meeting Business Wire
May-02-19 04:00PM  Quanterix to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019 Business Wire
Apr-01-19 07:14AM  Will Quanterix Corporation's (NASDAQ:QTRX) Earnings Grow In The Next Couple Of Years? Simply Wall St. -9.41%
Mar-28-19 04:00PM  Quanterix Appoints Amol Chaubal as Chief Financial Officer Business Wire
Mar-18-19 05:48PM  Quanterix Corp (QTRX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-08-19 01:15AM  Quanterix Corporation (QTRX) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-07-19 04:00PM  Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2018 Business Wire
Feb-26-19 04:00PM  Quanterix to Release Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Thursday, March 7, 2019 Business Wire
Feb-21-19 02:45PM  Quanterix to Present at Multiple Upcoming Healthcare Conferences Business Wire
Feb-19-19 06:04AM  Could a blood test predict Alzheimer's disease 16 years before symptoms? American City Business Journals
Jan-14-19 11:45AM  Quanterix to Present at 21st Annual Needham Growth Conference Business Wire -6.43%
Jan-10-19 12:00PM  Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X Platform and CorPlex Validated 10-Plex Business Wire +9.31%
Jan-04-19 04:17PM  Quanterix Marks One-Year Anniversary of IPO with Key Milestones Accelerating Healthcare Disruption Ahead of Presentation at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-20-18 10:11AM  Have Insiders Been Selling Quanterix Corporation (NASDAQ:QTRX) Shares This Year? Simply Wall St.
Dec-13-18 03:08PM  Facing headwinds, medtech sector won't be left to its own devices American City Business Journals
Nov-26-18 01:00PM  Quanterix to Present at the Evercore ISI HealthCONx Conference Business Wire
Nov-21-18 08:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Okta, One Horizon Group, Vivopower International Plc, PetIQ, Quanterix, and Eidos Therapeutics New Research Emphasizes Economic Growth GlobeNewswire
Nov-13-18 04:00PM  Quanterix to Present at the Canaccord Genuity Medical Technologies & Diagnostic Forum Business Wire
Nov-07-18 09:00AM  Quanterix Expanding Transformative Biomarker Technology Portfolio Into Oncology Business Wire
Nov-01-18 04:00PM  Quanterix Corporation Releases Operating Results for Third Quarter 2018 Business Wire
Oct-25-18 04:05PM  Quanterix to Release Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 1, 2018 Business Wire
Oct-22-18 04:30PM  Quanterix Announces Collaboration with OncoGenesis to Develop Cervical Screening Test Business Wire
Oct-09-18 12:00AM  Quanterix Simoa Technology Powers Record Number of Presentations and Poster Sessions at ECTRIMS 2018 Business Wire
Sep-26-18 09:00AM  Quanterix Simoa Technology Reveals Link Between Soccer Headers and Concussions for the First Time Business Wire +7.23%
Sep-18-18 10:45AM  Quanterix CEO Leads Webinar on How Digital Biomarkers are Empowering Drug Development Business Wire +12.34%
Sep-12-18 05:15PM  Quanterix Announces Termination of License Agreement with bioMérieux Business Wire
Sep-05-18 09:00AM  Quanterix to Speak at Wells Fargo Securities 2018 Healthcare Conference Business Wire
Aug-08-18 04:00PM  Quanterix Corporation Releases Operating Results for Second Quarter 2018 Business Wire
Aug-06-18 09:32AM  Simoa Technology Unlocks Insights from Previously Obscure Biomarker Business Wire
Jul-30-18 09:00AM  Quanterix to Present at the Canaccord Genuity 38th Annual Growth Conference Business Wire
Jul-26-18 09:00AM  Quanterix to Release Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 8, 2018 Business Wire
Jul-23-18 01:00PM  Quanterix Ultra-Sensitive Technology Creates Breakthroughs in Brain Health of Military and Veterans Business Wire
Jun-13-18 09:30AM  EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of Powering Precision Health as an Entrepreneur Of The Year® 2018 Award Finalist in the New England Region Business Wire
May-09-18 04:00PM  Quanterix Corporation Releases Operating Results for First Quarter 2018 Business Wire
May-02-18 09:00AM  Quanterix to Release First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018 Business Wire
Apr-27-18 09:00AM  Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone Business Wire
Mar-21-18 11:00AM  Quanterix to Present at Needham and Companys 17th Annual Healthcare Conference Business Wire
Mar-20-18 09:00AM  Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection Business Wire
Mar-14-18 04:05PM  Quanterix Corporation Releases Operating Results for Fourth Quarter and Fiscal Year 2017 Business Wire
Mar-08-18 08:00AM  New Research Demonstrates Enhanced Sensitivity for Acute HIV Detection Using Quanterix Simoa Technology Business Wire
Mar-07-18 12:56PM  Quanterix to Present at the Cowen and Company 38th Annual Healthcare Conference Business Wire
Feb-08-18 10:00AM  Quanterix to Present at The LEERINK Partners 7th Annual Global Healthcare Conference Business Wire
Jan-22-18 04:52PM  Quanterix Uses JPMorgan Healthcare Conference to Scout Sales Candidates TheStreet.com
Jan-04-18 09:03AM  Quanterix Corporation to Present at 36th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-02-18 11:35AM  Quanterix Announces Commercial Availability of New SR-X Ultra-Sensitive Biomarker Detection System Business Wire
Dec-13-17 06:15PM  Quanterix Corp (QTRX) EC, President & CEO E Kevin Hrusovsky Bought $510,000 of Shares GuruFocus.com
Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roskey Mark T.SVP, Commercial & AcceleratorJan 21Option Exercise2.965,00014,80019,239Jan 22 05:12 PM
Roskey Mark T.SVP, Commercial & AcceleratorJan 21Sale24.045,000120,18214,239Jan 22 05:12 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 21Sale24.076,500156,4441,144,342Jan 22 05:12 PM
Duffy David C.SVP R&D and CTOJan 17Option Exercise1.931,9413,74653,301Jan 17 08:46 PM
Duffy David C.SVP R&D and CTOJan 17Sale23.991,94146,56551,360Jan 17 08:46 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 17Sale24.416,500158,6651,150,842Jan 17 08:40 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 15Sale22.176,500144,1301,157,342Jan 17 08:40 PM
Madaus Martin DDirectorJan 09Option Exercise1.931,6003,08811,202Jan 09 05:53 PM
Madaus Martin DDirectorJan 09Sale21.942,30050,462201,966Jan 09 05:53 PM
Madaus Martin DDirectorJan 09Sale22.331,60035,7289,602Jan 09 05:53 PM
Madaus Martin DDirectorJan 08Option Exercise1.931,6003,08811,202Jan 09 05:53 PM
Madaus Martin DDirectorJan 08Sale22.782,30052,383204,266Jan 09 05:53 PM
Madaus Martin DDirectorJan 08Sale23.151,60037,0429,602Jan 09 05:53 PM
Roskey Mark T.SVP, Commercial & AcceleratorJan 02Sale23.18461,06614,239Jan 06 04:05 PM
HRUSOVSKY E KEVINChairman, President & CEOJan 02Sale23.183,32176,9661,163,842Jan 06 04:04 PM
Mattoon DawnSr. VP, Research ProductsJan 02Sale23.181152,66522,241Jan 06 04:04 PM
Madaus Martin DDirectorDec 27Option Exercise1.931,6003,0888,149Dec 30 04:23 PM
Madaus Martin DDirectorDec 27Sale23.272,30053,523206,566Dec 30 04:23 PM
Madaus Martin DDirectorDec 27Sale23.631,60037,8066,549Dec 30 04:23 PM
Madaus Martin DDirectorDec 26Option Exercise1.931,6003,0888,149Dec 30 04:23 PM
Madaus Martin DDirectorDec 26Sale24.092,30055,408208,866Dec 30 04:23 PM
Madaus Martin DDirectorDec 26Sale24.251,60038,7956,549Dec 30 04:23 PM
Duffy David C.SVP R&D and CTODec 18Option Exercise2.286,60015,04851,360Dec 20 06:40 PM
Duffy David C.SVP R&D and CTODec 16Option Exercise1.931,6673,21746,427Dec 16 04:17 PM
Duffy David C.SVP R&D and CTODec 16Sale24.151,66740,25844,760Dec 16 04:17 PM
Madaus Martin DDirectorDec 11Option Exercise1.931,6003,0888,149Dec 11 06:48 PM
Madaus Martin DDirectorDec 11Sale25.362,30058,321211,166Dec 11 06:48 PM
Madaus Martin DDirectorDec 11Sale25.251,60040,4006,549Dec 11 06:48 PM
Madaus Martin DDirectorDec 10Option Exercise1.931,6003,0888,149Dec 11 06:48 PM
Madaus Martin DDirectorDec 10Sale25.132,30057,793213,466Dec 11 06:48 PM
Madaus Martin DDirectorDec 10Sale24.811,60039,6966,549Dec 11 06:48 PM
HRUSOVSKY E KEVINChairman, President & CEODec 02Sale25.063,35784,1361,167,163Dec 03 08:29 PM
Mattoon DawnSr. VP, Research ProductsDec 02Sale25.061152,88222,356Dec 03 08:29 PM
Roskey Mark T.SVP, Commercial & AcceleratorDec 02Sale25.06471,17814,285Dec 03 08:29 PM
Madaus Martin DDirectorNov 26Option Exercise1.931,6003,0888,149Nov 26 05:33 PM
Madaus Martin DDirectorNov 26Sale25.072,30057,660215,766Nov 26 05:33 PM
Madaus Martin DDirectorNov 26Sale25.401,60040,6406,549Nov 26 05:33 PM
Madaus Martin DDirectorNov 25Option Exercise1.931,6003,0888,149Nov 26 05:33 PM
Madaus Martin DDirectorNov 25Sale25.402,30058,425218,066Nov 26 05:33 PM
Madaus Martin DDirectorNov 25Sale24.871,60039,7886,549Nov 26 05:33 PM
Duffy David C.SVP R&D and CTONov 18Option Exercise1.931,6673,21746,427Nov 19 06:18 PM
Duffy David C.SVP R&D and CTONov 18Sale22.561,66737,61544,760Nov 19 06:18 PM
Madaus Martin DDirectorNov 13Option Exercise1.931,6003,0888,149Nov 14 04:31 PM
Madaus Martin DDirectorNov 13Sale21.782,30050,097220,366Nov 14 04:31 PM
Madaus Martin DDirectorNov 13Sale22.041,60035,2646,549Nov 14 04:31 PM
Madaus Martin DDirectorNov 12Option Exercise1.931,6003,0888,149Nov 14 04:31 PM
Madaus Martin DDirectorNov 12Sale22.232,30051,134222,666Nov 14 04:31 PM
Madaus Martin DDirectorNov 12Sale22.281,60035,6436,549Nov 14 04:31 PM